Crescent Capital BDC CCAP
Crescent Capital BDC Q1 FY25: net income $3.9M, down 86%; diluted EPS $0.45
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000950170-25-071368
Key figures from this report
These are the numbers Crescent Capital BDC reported for Q1 FY25, the quarter ended Mar 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Net income$3.9M−86% from $28.0M in Q1 FY2410-Q income statement, on EDGAR
- Diluted EPS$0.45−29% from $0.63 in Q1 FY2410-Q income statement, on EDGAR
- Cash and cash equivalents$12.0M+78% from $6.7M in Q1 FY2410-Q balance sheet, on EDGAR
- Cash from operations−$15.1M−138% from $39.5M in Q1 FY2410-Q cash flow statement, on EDGAR
